April 9, 2024

National Journal Devotes Issue to Project Led by TRI’s Laura James, M.D.

David Robinson

UAMS Translational Research Institute Director Laura James, M.D., led a team of five guest editors from institutions across the United States who were published on their efforts to improve clinical trials.

UAMS Translational Research Institute (TRI) Director Laura James, M.D., concluded her tenure as co-chair of the national Clinical and Translational Sciences Award (CTSA) Steering Committee in December with an effort aimed at making clinical trials more informative and of higher quality. Her work, and those of other CTSA leaders, appears in a themed issue of…

April 4, 2024

NIH Awards UAMS Researchers $2.27 Million to Study Estrogen’s Role in Preventing Bone Loss

David Robinson

UAMS’ Maria Schuller Almeida, Ph.D. (left), and Ha-Neui (Hans) Kim, Ph.D., will use new funding from the National Institutes of Health to answer key questions about estrogen’s important role in preventing bone loss.

LITTLE ROCK — Researchers at the University of Arkansas for Medical Sciences (UAMS) will use a $2.27 million grant from the National Institutes of Health (NIH) to answer key questions about the cellular mechanisms used by estrogen to prevent bone loss and osteoporosis. The five-year NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases…

April 3, 2024

Three UAMS Research Teams Named Inaugural Recipients of BioVentures Accelerator Awards

David Robinson

UAMS’ Gyan Sahukhal, Ph.D., Samir Jenkins, Ph.D., and Mitchell McGill, Ph.D., are the first researchers to receive financial and other support from the new AR Health Ventures Accelerator (ARHVA) program.

BioVentures LLC at UAMS recently announced the selection of three UAMS research teams as the inaugural recipients of its new AR Health Ventures Accelerator (ARHVA) program. The accelerator program, which aims to help jump-start the translation of promising scientific discoveries into therapies, is providing the selected projects with substantial benefits, including financial grants up to…

March 20, 2024

UAMS Students Shine in Student Research Day Presentations

Nathan Tidwell

SRD Students

Graduate and professional students, postdoctorate fellows, and medical house staff presented research to faculty and peers during Student Research Day at the University of Arkansas for Medical Sciences (UAMS). Nobel Prize winner Craig C. Mello, Ph.D., spoke as part of the Robert E. McGehee Jr., Ph.D., Distinguished Lectureship in Biomedical Research. A concurrent Student Research…

February 6, 2024

UAMS Research Team Discovers Potential Alzheimer’s Drug

David Robinson

UAMS' Sue Griffin, Ph.D., and Meenakshisundaram, Balasubramaniam, Ph.D., led the discovery of the potential Alzheimer's drug for people with the inherited Alzheimer's gene.

LITTLE ROCK — A potential new drug to prevent Alzheimer’s disease in people with the so-called Alzheimer’s gene has been discovered by a University of Arkansas for Medical Sciences (UAMS) research team led by Sue Griffin, Ph.D. The findings were published Jan. 8 in Communications Biology and include discoveries of a druggable target and a…

January 30, 2024

Teenage Researcher Leads UAMS Parkinson’s Study Published in Scientific Reports

David Robinson

Anu Iyer began working on the machine learning Parkinson's disease study at UAMS as a high school student.

LITTLE ROCK — Eighteen-year-old Anu Iyer, the recent Little Rock Central High School graduate and machine-learning sensation collaborating with a University of Arkansas for Medical Sciences (UAMS) research team, is the lead author on a publication in Scientific Reports, part of the Nature portfolio journals. She was joined as co-first author by UAMS’ Aaron Kemp,…

January 19, 2024

Arkansan Sees Advanced Cancer Disappear with Experimental Drug Offered at UAMS Winthrop P. Rockefeller Cancer Institute

Marty Trieschmann

Dr. Michael Birrer speaks with a patient during a clinic visit

A Little Rock man with resistant kidney cancer who underwent experimental immunotherapy in Phase 1 Clinical Trials at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has experienced a complete remission.

November 15, 2023

NIH Awards UAMS $1.54 Million to Tackle Brittle Bone Disease

David Robinson

Roy Morello, Ph.D., in his lab at UAMS.

LITTLE ROCK — A UAMS research team is using a $1.54 million grant from the National Institutes of Health (NIH) to support its goal of finding better treatments for osteogenesis imperfecta (OI), also known as brittle bone disease. The four-year award from the NIH National Heart, Lung, and Blood Institute will allow Roy Morello, Ph.D.,…

November 6, 2023

UAMS BioVentures Awarded Nearly $3 Million for Health Tech Entrepreneurship Program, Invited to White House

David Robinson

UAMS' Kevin Sexton, M.D. (left), president of BioVentures, chats with Donald “Don” Cravens Jr., under secretary of Commerce for the Minority Business Development Agency, during a ceremony at the White House to celebrate the Capital Readiness Program.

LITTLE ROCK — BioVentures LLC at the University of Arkansas for Medical Sciences (UAMS) has secured a nearly $3 million grant from the U.S. Department of Commerce to support entrepreneurs from socially and economically disadvantaged backgrounds who are looking to develop health technology and health care businesses in Arkansas. The four-year $2,999,997 grant comes from…

October 20, 2023

Investigators Soak in Research Expo 2023’s Abundant Resources, Services

David Robinson

TRI's David Avery, senior director of Clinical Research Operations, and Carrie Cochran-Raglon, director of the UAMS Rural Research Network, talk with Lipika Sarangi, Ph.D. (right).

Alberto Ramirez, Ph.D., was excited to attend Research Expo 2023, with its 50 research services and resources on display. “As an early-career researcher, the event proved to be remarkably valuable as it allowed me to gain insight into the numerous resources offered by UAMS, including TRI, Research & Innovation, and more, which have the potential…

Next page